Loading Events

« All Events

  • This event has passed.

T Cell Receptor Targeting CD22 for the Treatment of Lymphomas and Leukemias

May 31, 2023 @ 11:00 am - 12:00 pm

Free

Register to attend a free NIH webinar. Attendees will learn about a new T-cell receptor (TCR) that targets CD22, being developed by the National Cancer Institute (NCI) as a cellular immunotherapy to treat lymphomas and leukemias. CD22 TCR-T cells clear leukemia at clinically relevant doses without causing systemic cytokine elevation.

The webinar will highlight:

  • Novel CD22 specific TCR-T cells reducing tumor burden at clinically relevant doses

A new therapeutic method using these novel CD22 specific TCR-T cells that overcomes current treatment limitations for hematologic malignancies.

Details

Date:
May 31, 2023
Time:
11:00 am - 12:00 pm
Cost:
Free
Website:
https://cbiit.webex.com/weblink/register/r095f03d2ef8d5133f3f5a482f796cb34

Organizer

NIH|NCI Tech Transfer Center
Email:
rouault@mail.nih.gov
Website:
https://techtransfer.cancer.gov/